Back
EHRA Premium Access

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Session: Pathophysiology of atrial fibrillation and beyond I
Topic: Pathophysiology and Mechanisms
Speaker: Miss A. Khashaba (Birmingham, GB)
Event: EHRA 2021

Congress Presentation

About the speaker

Miss Alya Khashaba

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Impact of atrial fibrillation pattern on left atrial appendage closure: insights from the prospective LAARGE registry

Speaker: Doctor S. Kany (Cambridge, US)

Access
Abstract
Slides
Video
Thumbnail

Sacubitril/valsartan therapy and supraventricular arrhythmias detected through remote monitoring in heart failure patients

Speaker: Associate Professor F. Guerra (Ancona, IT)

Access
Abstract
Slides
Video
Thumbnail

RNA-seq profiling of the atrial transcriptome reveals gender-specific patterns and interactions with atrial fibrillation and heart failure

Speaker: Mr D. Balamurali (Maastricht, NL)

Access
Abstract
Slides
Video
Thumbnail

Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive fibrosis

Speaker: Mr L. Hopman (Amsterdam, NL)

Access
Abstract
Slides
Video
Thumbnail

Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Speaker: Doctor A. Papazoglou (Athens, GR)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Pathophysiology of atrial fibrillation and beyond I

Speakers: Miss A. Khashaba, Doctor S. Kany, Associate Professor F. Guerra, Mr D. Balamurali, Mr L. Hopman...
Access
Thumbnail

About the event

Image

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb